Rhythm Pharma Files Q1 2025 10-Q, Reports $623.9M Assets
Ticker: RYTM · Form: 10-Q · Filed: May 7, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, stock-offering
TL;DR
Rhythm Pharma Q1 2025: $623.9M assets, $63.5M liabilities, common stock offerings.
AI Summary
Rhythm Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $623.9 million and total liabilities of $63.5 million as of March 31, 2025. During the first quarter of 2025, Rhythm Pharmaceuticals engaged in at-market offerings of common stock.
Why It Matters
This filing provides a snapshot of Rhythm Pharmaceuticals' financial health and operational activities for the first quarter of 2025, including its asset and liability positions and stock offering activities.
Risk Assessment
Risk Level: medium — The company's financial position and ongoing stock offerings indicate potential financial risks and market activity.
Key Numbers
- $623.9M — Total Assets (As of March 31, 2025)
- $63.5M — Total Liabilities (As of March 31, 2025)
- 20250331 — Reporting Period End Date (Quarterly filing)
Key Players & Entities
- Rhythm Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- $623.9 million (dollar_amount) — Total assets as of March 31, 2025
- $63.5 million (dollar_amount) — Total liabilities as of March 31, 2025
- 20250331 (date) — Conformed period of report
FAQ
What were Rhythm Pharmaceuticals' total assets and liabilities as of March 31, 2025?
As of March 31, 2025, Rhythm Pharmaceuticals reported total assets of $623.9 million and total liabilities of $63.5 million.
What type of stock offering did Rhythm Pharmaceuticals engage in during the first quarter of 2025?
Rhythm Pharmaceuticals engaged in 'AtMarketOfferingsMember' of common stock during the period from January 1, 2025, to March 31, 2025.
What is the filing date of this 10-Q report?
The filing date for this 10-Q report is May 7, 2025.
What is the fiscal year end for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals' fiscal year ends on December 31.
What was the previous name of Rhythm Pharmaceuticals, Inc. and when did the name change occur?
The former company name was Rhythm Metabolic, Inc., and the date of the name change was August 3, 2015.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).